Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antacids Market
Antacids Market Size
- Report ID: GMI9703
- Published Date: May 2024
- Report Format: PDF
Antacids Market Size
Antacids market size was valued at around USD 7.1 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032. Antacids are medications used to neutralize stomach acid, providing relief from symptoms such as heartburn, indigestion, and acid reflux. These over-the-counter (OTC) drugs or prescription drugs work by reacting with gastric acid to form salts and water, thereby raising the pH level in the stomach and reducing acidity.
The rising prevalence of gastrointestinal disorders such as peptic ulcers, gastritis, gastroesophageal reflux disease, serves as a significant driving factor for the market. For instance, according to the National Institutes of Health (NIH), the global prevalence of peptic ulcer disease surged from approximately 6,434,103 cases to 8,090,476 cases in 2019, globally. This underscores the pressing need for effective treatments and symptomatic relief, fueling the demand for antacid medications and driving growth in the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Antacids Market Size in 2023: | USD 7.1 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 5.1% |
| 2032 Value Projection: | USD 11 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 281 |
| Tables, Charts & Figures: | 353 |
| Segments covered: | Type, Indication, Dosage, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Furthermore, dietary and lifestyle changes, increased awareness and self-medication, and pharmaceutical advancements, are the promoting factors advancing the growth of the market.
Frequently Asked Questions (FAQ) :
Antacids Market Scope
